sr 11237 has been researched along with liarozole in 1 studies
Studies (sr 11237) | Trials (sr 11237) | Recent Studies (post-2010) (sr 11237) | Studies (liarozole) | Trials (liarozole) | Recent Studies (post-2010) (liarozole) |
---|---|---|---|---|---|
26 | 0 | 9 | 101 | 23 | 14 |
Protein | Taxonomy | sr 11237 (IC50) | liarozole (IC50) |
---|---|---|---|
Cytochrome P450 26A1 | Homo sapiens (human) | 3.29 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.54 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.354 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 4.76 | |
Aromatase | Homo sapiens (human) | 0.0248 | |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | Homo sapiens (human) | 0.0023 | |
Cytochrome P450 26B1 | Homo sapiens (human) | 0.018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Astruc-Diaz, F; Buttrick, B; Diaz, P; Fronczek, FR; Guilloteau, N; Huang, W; Isoherranen, N; Keyari, CM; Price, L; Sperandio, VG; Tripathy, S | 1 |
1 other study(ies) available for sr 11237 and liarozole
Article | Year |
---|---|
Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase.
Topics: Algorithms; Animals; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Drug Design; Drug Resistance; Enzyme Induction; Enzyme Inhibitors; Humans; Isoenzymes; Kinetics; Liver; Rats; Retinoic Acid 4-Hydroxylase; Structure-Activity Relationship; Substrate Specificity; Tretinoin | 2016 |